Prostate Cancer: Interprofessional Collaboration and Pharmacologic Care
Target Audience: Pharmacy Tech
Course Overview
Prostate cancer is the most frequently diagnosed cancer among men and a leading cause of cancer-related mortality. Approximately one in eight men will be diagnosed with prostate cancer during their lifetime. Despite advancements in screening and treatment, this condition remains a public health challenge due to its heterogeneity, variable progression, and disparities in outcomes across racial and socioeconomic populations. Within this continuing education activity, participants will review the etiology, risk factors, staging, and diagnosis of prostate cancer. This activity will also review available treatment options, including chemotherapy, hormone therapy, immunotherapy, and emerging agents. Throughout the activity, an emphasis will be placed on interprofessional communication and shared decision-making
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Describe the pathophysiology, staging, and risk factors associated with prostate cancer
- Compare and Contrast pharmacologic agents used in the treatment of prostate cancer
- Identify supportive care strategies for patients undergoing treatment for prostate cancer
- Describe the importance of multidisciplinary care and shared decision-making in the management of prostate cancer
Faculty
I. Introduction
II. Collaborative Care in Prostate Cancer Management
III. Prostate Cancer Epidemiology and Etiology
IV. Pathophysiology
V. Screening and Prevention
VI. Evaluation and Diagnosis
A. Clinical Presentation
B. Staging
VII. Treatment Approach
A. General Approach
B. Localized Disease Management
VIII. Locally Advanced and High-Risk Disease
IX. Metastatic Disease Management
X. Pharmacotherapy
A. LHRH Agonists
B. GnRH Antagonists
C. Antiandrogens
D. Combined Androgen Blockade (CAB)
E. Abiraterone
F. Chemotherapy
G. Immunotherapy
H. Targeted Therapy
XI. Shared Decision-Making in Prostate Cancer Care
XII. Summary
From July 18, 2025 through July 18, 2028, participants must:
- Read the "learning objectives" and "author and planning team disclosures"
- Study the section entitled "educational activity"
- Complete the Course Test and Evaluation form. The Course Test will be graded automatically. Following successful completion of the Course Test with a score of 70% or higher, a statement of participation will be made available immediately. (No partial credit will be given.)
Credit for this course will be automatically uploaded to CPE Monitor®.
Faculty Planner Disclosure
The following individuals were involved in developing this activity: L. Austin Fredrickson, MD, FACP, Liz Fredrickson, PharmD, BCPS, Kristina (Tia) Neu, RN, and Pamela Sardo, PharmD, BS. None of the individuals involved in developing this activity has a conflict of interest or financial relationships related to the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.
Unlabeled Use Disclosure
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Please ensure the device you plan to use meets these requirements:
- Operating System: Windows 7, 8, 10, or 11 / Mac OS X 10.9 or later / iOS / Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
Accreditation
In support of improving patient care, RxCE.com is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PTCB Recognition
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".